Articles tagged with Allosteric Regulation
Scientists have captured detailed images of NMDA receptors held open by natural gatekeepers and synthetic regulators, revealing how they control ion flow. This understanding can inform the design of safe and effective therapies for conditions like Alzheimer's disease and stroke.
Researchers at CCM Biosciences have discovered novel enzyme activators that fully restore the activity of Sirtuin-3, a master regulator of cellular energy production. These compounds hold significant potential for addressing age-related disorders such as Alzheimer's and Parkinson's diseases.
Researchers have identified a potential compound that enhances naloxone's effectiveness in reversing opioid overdoses by making it more potent and longer-lasting. The compound, dubbed compound 368, was found to improve naloxone's ability to counteract opioid overdoses in mice and enable reversal at lower doses.
Researchers found that obesity increases allosteric regulation during feeding and decreases it when fasting in mice livers. This disruption may lead to metabolic disorders like nonalcoholic fatty liver disease and Type 2 diabetes.
The study reveals a quantum switching mechanism of LHCII, which regulates energy transfer quantum channel in response to lateral pressure and conformational change. This mechanism enables high efficiency in photosynthesis and balanced photoprotection.
Scientists at the Max Planck Institute have uncovered how ExoY toxin becomes activated in human cells by binding to actin filaments, leading to devastating enzymatic activity. This discovery sheds light on a crucial molecular mechanism that underlies the pathogenicity of various toxins.
A Nagoya University team has discovered a process called allosteric regulation in plants, which helps maintain the balance of phytohormones gibberellin and auxin. This finding could lead to improved rice crop productivity and provide a solution for food security.
Recent studies have highlighted the significant role of Shp2, a phosphatase protein, in governing signaling response amplitude and regulating cell differentiation and growth. Dysregulation of Shp2 has been linked to various types of leukemia, including acute myeloid, juvenile myelomonocytic, and B-cell acute lymphoblastic leukemia.
A previously unpublished work by Francis Crick and Jeffries Wyman from 1965 is now available, proposing a different formulation of the Monod-Wyman-Changeux hypothesis. The paper analyzes how regulatory performances of monomeric proteins are enhanced by assembly into cooperative structures.